ReviewBJR artificial intelligence2024
Applications and implementation of generative artificial intelligence in cardiovascular imaging with a focus on ethical and legal considerations: what cardiovascular imagers need to know!
Review in BJR artificial intelligence, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Ethical Considerations in Patient Privacy and Data Handling for AI in Cardiovascular Imaging and Radiology.Journal of imaging informatics in medicine · 2026Review
- Artificial Intelligence in Pediatric Cardiology: Present Applications and Future Directions.Pediatric reports · 2026Review
- A perspective on AI implementation in medical imaging in LMICs: challenges, priorities, and strategies.European radiology · 2026Article
- Prognostication and clinical opportunities with AI for coronary artery calcium: a scoping review.BMJ digital health & AI · 2026Article
- Comparison of artificial intelligence-enhanced electrocardiography approaches for the prediction of time to mortality using electrocardiogram images: reply.European heart journal. Digital health · 2025Article
- A narrative review on ethical considerations and challenges in AI-driven cardiology.Annals of medicine and surgery (2012) · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Machine learning (ML) and deep learning (DL) have potential applications in medicine. This overview explores the applications of AI in cardiovascular imaging, focusing on echocardiography, cardiac MRI (CMR), coronary CT angiography (CCTA), and CT morphology and function. AI, particularly DL approaches like convolutional neural networks, enhances standardization in echocardiography. In CMR, undersampling techniques and DL-based reconstruction methods, such as variational neural networks, improve efficiency and accuracy. ML in CCTA aids in diagnosing coronary artery disease, assessing stenosis severity, and analyzing plaque characteristics. Automatic segmentation of cardiac structures and vessels using AI is discussed, along with its potential in congenital heart disease diagnosis and 3D printing applications. Overall, AI integration in cardiovascular imaging shows promise for enhancing diagnostic accuracy and efficiency across modalities. The growing use of Generative Adversarial Networks in cardiovascular imaging brings substantial advancements but raises ethical concerns. The "black box" problem in DL models poses challenges for interpretability crucial in clinical practice. Evaluation metrics like ROC curves, image quality, clinical relevance, diversity, and quantitative performance assess GAI models. Automation bias highlights the risk of unquestioned reliance on AI outputs, demanding careful implementation and ethical frameworks. Ethical considerations involve transparency, respect for persons, beneficence, and justice, necessitating standardized evaluation protocols. Health disparities emerge if AI training lacks diversity, impacting diagnostic accuracy. AI language models, like GPT-4, face hallucination issues, posing ethical and legal challenges in healthcare. Regulatory frameworks and ethical governance are crucial for fair and accountable AI. Ongoing research and development are vital to evolving AI ethics.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.